🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementAnyone else get weird vivid dreams on sema?? — looking for input

Anyone else get weird vivid dreams on sema?? — looking for input

LeilaHI Sun, Aug 24, 2025 at 8:19 PM 13 replies 1,432 viewsPage 1 of 3
This thread is more than 9 months old. Information may be outdated. Consider searching for more recent discussions.
LeilaHI
Member
167
789
Jan 2025
Honolulu, HI
Aug 24, 2025 at 8:19 PM#1

Nausea arrived on day two of each dose step, lasted about four days, and disappeared entirely by the second week — until the step where it did not.

The bit I cannot resolve on my own is whether holding at a lower dose for longer actually reduces total side-effect burden or just spreads it out.

If the honest answer is that nobody knows, that is a useful answer and I would rather have it.

10 5COA_Karl, MikeFit_NJ, InsuranceTom and 7 others
Reply Quote Save Share Report
BariatricNurseD
Senior Member
1,678
7,234
Feb 2024
Dallas, TX
Online
Aug 24, 2025 at 8:44 PM#2

This one has a reasonably settled answer, so here it is. The practical protocol is dull and it works: smaller meals, stop eating at the first sign of fullness rather than at the end of the plate, drop the fat fraction of meals in the two days after dosing, and do not lie down straight after eating. Most of what people call unmanageable nausea is a meal-size and meal-composition problem interacting with a stomach that is emptying slowly.

9 4roxy_nash, tony_orlando, Dr.NephBHM_UK and 6 others
Reply Quote Save Share Report
nick_newbie
New Member
18
56
Jun 2026
Virginia
Online
Aug 24, 2025 at 9:09 PM#3
BariatricNurseD said:
The practical protocol is dull and it works: smaller meals, stop eating at the first sign of fullness rather than at the end of the plate, drop the…

Agreeing with BariatricNurseD, and the qualification matters more than the agreement. The meal advice is right and incomplete without the hydration point. People stop drinking because drinking makes them feel full, then attribute dehydration symptoms to the drug.

8 3MeganSA_TX, LarryQC_SD, wanda_boise and 5 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
TomTeleRx
Member
189
678
Feb 2025
Delaware
Aug 24, 2025 at 9:34 PM#4
LeilaHI said:
Nausea arrived on day two of each dose step, lasted about four days, and disappeared entirely by the second week — until the step where it did not.

Same position here, arrived at the long way round. Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts. Receptor-level tachyphylaxis to the delayed-emptying effect develops over weeks while the central appetite effect persists, so the same dose is materially more comfortable at week six than at week two. A slower ladder therefore reaches the same dose with less cumulative nausea, not the same nausea spread thinner.

Last edited: Aug 24, 2025 at 10:34 PM
7 2HPLC_Greg, LibrarianMeg, bri_stats and 4 others
Reply Quote Save Share Report
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Aug 24, 2025 at 11:53 PM#5

Clinical perspective, offered as context rather than as advice. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

6 1lori_vegas, Dr.PulmRoch, maya_sedona and 3 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register